Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study

Cited by (283)

Items 101–200 of 283

1. The Influence of SARS-CoV-2 Variants on National Case-Fatality Rates: Correlation and Validation Study
   William A. Barletta · 2022 · JMIRx Med
2. Functional Profiling of In Vitro Reactivated Memory B Cells Following Natural SARS-CoV-2 Infection and Gam-COVID-Vac Vaccination
   Ekaterina A. Astakhova, Maria G. Byazrova, Gaukhar M. Yusubalieva, Кулемзин Сергей Викторович, Natalia A. Kruglova, Alexei G. Prilipov, Vladimir P. Baklaushev, Andrey A. Gorchakov, Alexander V. Taranin, Alexander V. Filatov · 2022 · Cells
3. Tissue-Resident Memory T Cell: Ontogenetic Cellular Mechanism and Clinical Translation
   Haoran Xu, Runhong Zhou, Zhiwei Chen · 2023 · Clinical & Experimental Immunology
4. COVID-19 Pandemic: Public Health Risk Assessment and Risk Mitigation Strategies
   Dae-Young Kim, Surendra Krushna Shinde, Saifullah Lone, Ramasubba Reddy Palem, Gajanan Sampatrao Ghodake · 2021 · Journal of Personalized Medicine
5. Comparative Immunogenicity of COVID-19 Vaccines in a Population-Based Cohort Study with SARS-CoV-2-Infected and Uninfected Participants
   David Peterhoff, Sebastian Einhauser, Stephanie Beileke, Hans-Helmut Niller, Felix Günther, Michael Schachtner, Benedikt Asbach, Philipp A. Steininger, Matthias Tenbusch, Antonia Sophia Peter et al. · 2022 · Vaccines
6. A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses
   Joseph Torresi, Melissa Anne Edeling, Terry M. Nolan, Dale Ian Godfrey · 2022 · Frontiers in Immunology
7. The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice
   Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, Snezhina Lazova, Lyubomir Chervenkov, Monika Peshevska-Sekulovska, Metodija Sekulovski, Milena Gulinac, Georgi Vasilev, L Tomov et al. · 2023 · Vaccines
8. Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study
   Lucy Li, Chunlei Zheng, Jennifer La, Nhan Do, Paul A. Monach, Judith M. Strymish, Nathanael R. Fillmore, Westyn Branch‐Elliman · 2022 · Vaccine
9. Modeling vaccination strategies with limited early COVID-19 vaccine access in low- and middle-income countries: A case study of Thailand
   Suparinthon Anupong, Tanakorn Chantanasaro, Chaiwat Wilasang, Natcha C. Jitsuk, Chayanin Sararat, Kan Sornbundit, Busara Pattanasiri, Dhammika Leshan Wannigama, Mohan Amarasiri, Sudarat Chadsuthi et al. · 2023 · Infectious Disease Modelling
10. COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
    M. Nathaniel Mead, Stephanie Seneff, Russell D. Wolfinger, Jessica Rose, Kris Denhaerynck, Steve Kirsch, Peter Andrew McCullough · 2024 · Cureus · Retracted
11. The STING Ligand and Delivery System Synergistically Enhance the Immunogenicity of an Intranasal Spike SARS-CoV-2 Vaccine Candidate
    Tuksin Jearanaiwitayakul, Jitra Limthongkul, Chernkhwan Kaofai, Suttikarn Apichirapokey, Runglawan Chawengkirttikul, Sompong Sapsutthipas, Panya Sunintaboon, Sukathida Ubol · 2022 · Biomedicines
12. Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths
    Miguel Angel Ortega, Cielo García Montero, Oscar Fraile‐Μartinez, Paolo C. Colet, Ardak Baizhaxynova, Kymbat Mukhtarova, Melchor Álvarez‐Mon, Kaznagul Kanatova, Ángel Asúnsolo, Antonio Sarría‐Santamera · 2022 · Journal of Personalized Medicine
13. Update on COVID-19 and Effectiveness of a Vaccination Campaign in a Global Context
    Ioannis Alexandros Charitos, Andrea Ballini, Roberto Lovero, Francesca Castellaneta, Marica Colella, Salvatore Scacco, Stefania Cantore, Roberto Arrigoni, Filiberto Mastrangelo, Mario Dioguardi · 2022 · International Journal of Environmental Research and Public Health
14. Playing Russian Roulette with Every COVID-19 Injection: The Deadly Global Game
    Daniel Santiago · 2022 · International Journal of Vaccine Theory Practice and Research
15. Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents
    Tal Patalon, Yaki Saciuk, Hanit Ohayon Hadad, Asaf Peretz, Asaf Peretz, Amir Ben‐Tov, Sivan Gazit · 2023 · The Journal of Pediatrics
16. COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a preliminary assessment from a case-control study in St. Petersburg, Russia
    Антон Алексеевич Барчук, Anna Bulina, Mikhail Cherkashin, Natalia Berezina, Tatyana Rakova, Darya Kuplevatskaya, Oksana V. Stanevich, Dmitriy Skougarevskiy, Artemiy Okhotin · 2022 · BMC Public Health
17. Hybrid Immunity Provides Protective Advantage Over Vaccination or Prior Remote Coronavirus Disease 2019 Alone
    Abinash Virk, Matthew G. Johnson, Daniel L. Roellinger, Christopher G. Scott, Priya Sampathkumar, Laura E. Breeher, Melanie D. Swift · 2023 · Open Forum Infectious Diseases
18. Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19–Associated Encounters in Adults During Delta and Omicron Predominance
    Catherine H. Bozio, Kristen A. Butterfield, Melissa Briggs Hagen, Shaun J. Grannis, Paul E. Drawz, Emily Hartmann, Toan C. Ong, BRUCE H. FIREMAN, Karthik Natarajan, Kristin K. Dascomb et al. · 2023 · The Journal of Infectious Diseases
19. Booster or additional vaccination doses in patients vaccinated against COVID-19
    Alejandra García Botella, Alberto García‐Lledó, Javier Gómez‐Pavón, Juan María González del Castillo, Teresa Hernández‐Sampelayo, M.C. Martín Delgado, Francisco Javier Martín‐Sánchez, Manuel Martínez‐Sellés, José Molero, Santiago Moreno Guillén et al. · 2021 · Revista Española de Quimioterapia
20. Time-Varying Effect of Hybrid Immunity on the Risk of Breakthrough Infection after Booster Dose of mRNA COVID-19 Vaccine: The MOSAICO Study
    Pietro Ferrara, D. Ponticelli, Roberto Magliuolo, Mario Borrelli, Beniamino Schiavone, Lorenzo Giovanni Mantovani · 2022 · Vaccines
21. Projecting Omicron scenarios in the US while tracking population-level immunity
    Anass Bouchnita, Kaiming Bi, Spencer J. Fox, Lauren W. Ancel · 2024 · Epidemics
22. Variation in the Humoral Immune Response Induced by the Administration of the BNT162b2 Pfizer/BioNTech Vaccine: A Systematic Review
    Karen Cortés-Sarabia, Mayralina Gutiérrez-Torres, Escarlet Maleny Mendoza-Renteria, Marco Antonio Leyva‐Vázquez, Amalia Vences-Velázquez, Daniel Hernández‐Sotelo, Fredy Omar Beltrán‐Anaya, Óscar Del Moral-Hernández, Berenice Illades‐Aguiar · 2022 · Vaccines
23. Outcomes associated with SARS-CoV-2 reinfection in individuals with natural and hybrid immunity
    Geehan Suleyman, Raef Ali Fadel, Kunj Patel, Al Muthanna Shadid, Haim Bernardo Cotlear Stuart, Michael Kattula, Andrea Janis, Mohamed Maki, Shing Chao, George John Alangaden et al. · 2023 · Journal of Infection and Public Health
24. COVID‐19 vaccine adverse events: Evaluating the pathophysiology with an emphasis on sulfur metabolism and endotheliopathy
    Heidi N. du Preez, Johnson Lin, Glenn E. M. Maguire, Colleen Michelle Aldous, Hendrik Gerhardus Kruger · 2024 · European Journal of Clinical Investigation
25. A retrospective cohort study of incidence and risk factors for severe SARS-CoV-2 breakthrough infection among fully vaccinated people
    Tatjana Meister, Anastassia Kolde, Krista Fischer, Heti Pisarev, Raivo Kolde, Ruth Kalda, Kadri Suija, Anna Tisler, Anneli Uusküla · 2023 · Scientific Reports
26. The test‐negative design: Opportunities, limitations and biases
    Ronald W. J. Meester, Jan Bonte · 2023 · Journal of Evaluation in Clinical Practice
27. Risk of SARS-CoV-2 infection and hospitalization in individuals with natural, vaccine-induced and hybrid immunity: a retrospective population-based cohort study from Estonia
    Anneli Uusküla, Heti Pisarev, Anna Tisler, Tatjana Meister, Kadri Suija, Kristi Huik, Aare Abroi, Ruth Kalda, Raivo Kolde, Krista Fischer · 2023 · Scientific Reports
28. Decoupling between SARS-CoV-2 transmissibility and population mobility associated with increasing immunity from vaccination and infection in South America
    Marcelo Fiori, Gonzalo Bello, Nicolás Wschebor, Federico Lecumberry, Andrés Ferragut, Ernesto Mordecki · 2022 · Scientific Reports
29. Fully understanding the efficacy profile of the COVID-19 vaccination and its associated factors in multiple real-world settings
    Yunes Panahi, Behzad Einollahi, Fatemeh Beiraghdar, Mohammad Darvishi, Saeid Fathi, Mohammad Javanbakht, Sepehr Shafiee, Reza Akhavan‐Sigari · 2022 · Frontiers in Immunology
30. Incidence and outcome of SARS-CoV-2 reinfection in the pre-Omicron era: A global systematic review and meta-analysis
    Nabihah Farhana Ismail, Ahmed Ehsanur Rahman, Durga Kulkarni, Fuyu Zhu, Xin Wang, Graciela del Carmen Morales, Amit K. Srivastava, Kristen E. Allen, Júlia Spinardi, Moe Htet Kyaw et al. · 2023 · Journal of Global Health
31. The Effectiveness of Post-Vaccination and Post-Infection Protection in the Hospital Staff of Three Prague Hospitals: A Cohort Study of 8-Month Follow-Up from the Start of the COVID-19 Vaccination Campaign (COVANESS)
    Marek Petráš, Ivana Králová Lesná, Livia Večeřová, Elka Nyčová, Jana Malinová, Petr Klézl, Martina Nezvedová, Rachel Elizabeth White, Roman Máčalík, Jana Dáňová et al. · 2021 · Vaccines
32. The Impact of the Highly Virulent SARS-CoV-2 Gamma Variant on Young Adults in the State of São Paulo: Was It Inevitable?
    Beny Spira · 2022 · Cureus
33. Kinetics of Humoral Immunity against SARS-CoV-2 in Healthcare Workers after the Third Dose of BNT162b2 mRNA Vaccine
    Tiziana Grassi, Giambattista Lobreglio, Alessandra Panìco, Chiara Rosato, Antonella Zizza, Roberta Lazzari, Michele Chicone, Floriano Indino, Francesco Bagordo · 2022 · Vaccines
34. Maintaining immunological memory to the SARS-CoV-2 virus during COVID-19 pandemic
    А. П. Топтыгина, Zulfiia E. Afridonova, Закиров Рустам Шакирович, Elena L. Semikina · 2023 · Russian Journal of Infection and Immunity
35. ICD-10 based syndromic surveillance enables robust estimation of burden of severe COVID-19 requiring hospitalization and intensive care treatment
    Kristin Tolksdorf, Walter Haas, Ekkehard Schuler, Lothar H. Wieler, Julia Schilling, Osamah Hamouda, Michaela Diercke, Silke Buda · 2022 · medRxiv
36. Hamiltonian optimal control of quarantine against epidemic spreading on complex networks
    Yufei Fan, Xueyu Meng, Jun Liu, Jun-Chao Ma, Zhiqiang Cai, Shubin Si · 2025 · Chaos Solitons & Fractals
37. Long COVID: mechanisms of disease, multisystem sequelae, and prospects for treatment
    Seiya Oba, Tadashi Hosoya, Hideyuki Iwai, Shinsuke Yasuda · 2025 · Immunological Medicine
38. Two waves of COIVD-19 in Brazilian cities and vaccination impact
    Lixin Lin, Boqiang Chen, Yanji Zhao, Weiming Wang, Daihai He · 2022 · Mathematical Biosciences & Engineering
39. Measuring T-Cell Responses against SARS-CoV-2 Is of Utility for Disease and Vaccination Management
    Guillem Safont, Irene Latorre, Raquel Villar-Hernández, Zoran Stojanović, Alicia Marín, Cristina Pérez-Cano, Alícia Lacoma, Bárbara Molina-Moya, Alan Jhunior Solis, Fernándo Arméstar et al. · 2022 · Journal of Clinical Medicine
40. COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
    M. Nathaniel Mead, Stephanie Seneff, Russell D. Wolfinger, Jessica Rose, Kris Denhaerynck, Steve Kirsch, Peter Andrew McCullough · 2024 · International Journal of Vaccine Theory Practice and Research
41. COVID-19 vaccination decisions and impacts of vaccine mandates: a cross sectional survey of healthcare workers in Ontario, Canada
    Claudia Chaufan, Natalie Hemsing, Rachael Moncrieffe · 2024 · Journal of Public Health and Emergency
42. Vaccination and natural immunity: Advantages and risks as a matter of public health policy
    Adam Thomas Biggs, Lanny F Littlejohn · 2022 · The Lancet Regional Health - Americas
43. Incorporating mass vaccination into compartment models for infectious diseases
    Glenn Ledder · 2022 · Mathematical Biosciences & Engineering
44. Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care setting
    Madhura S. Rane, McKaylee M. Robertson, Sarah Kulkarni, Daniel Frogel, Chris Gainus, Denis Nash · 2022 · Vaccine
45. Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients
    Felix Dewald, Martin Pirkl, Martha Paluschinski, Joachim Kühn, Carina Elsner, Bianca Schulte, Jacqueline Knüfer, Elvin Ahmadov, Maike Schlotz, Göksu Oral et al. · 2023 · Nature Communications
46. Sequencing and mutations analysis of the first recorded SARS-CoV-2 Omicron variant during the fourth wave of pandemic in Iraq
    Jivan Qasim Ahmed, Sazan Qadir Maulud, Rawand Al‐Qadi, Teroj Abdulrahman Mohamed, Gahin Abdulraheem Tayib, Akheenk Mustafa Hassan, Luqman Saleh Taha, Khairi Mohammed Qasim, Mohammed Abid Tawfeeq · 2022 · The Brazilian Journal of Infectious Diseases
47. Comparison of the Development of SARS-Coronavirus-2-Specific Cellular Immunity, and Central Memory CD4+ T-Cell Responses Following Infection versus Vaccination
    Kevin M. Dennehy, Eva Loell, Christine Dhillon, Johanna-Maria Classen, Tobias Dominik Warm, Lukas Schuierer, Alexander Hyhlik-Dürr, Christoph Römmele, Yvonne Goßlau, Elisabeth Kling et al. · 2021 · Vaccines
48. Self-Selected COVID-19 “Unvaccinated” Cohort Reports Favorable Health Outcomes and Unjustified Discrimination in Global Survey
    Robert M. Verkerk, Naseeba Kathrada, Christof Plothe, Katarina Lindley · 2022 · International Journal of Vaccine Theory Practice and Research
49. Repetitive mRNA vaccination is required to improve the quality of broad-spectrum anti–SARS-CoV-2 antibodies in the absence of CXCL13
    Marne Azarias-da-Silva, Pierre Nioche, Calaiselvy Soudaramourty, Anne Bull-Maurer, Mounira Tiouajni, Dechuan Kong, Ouafa Zghidi‐Abouzid, Morgane Picard, Ana Mendes‐Frias, André Santa Cruz et al. · 2023 · Science Advances
50. A Comprehensive Review of mRNA-based Vaccines for COVID-19, A New Era in Pharmaceuticals: Unspecified and Unknown Aspects, Effects and Challenges
    Pegah Vosoughi, Seyed Morteza Naghib, Mehdi Rahmanian, M. R. Mozafari · 2025 · Current Topics in Medicinal Chemistry
51. Limited Impact of Delta Variant’s Mutations on the Effectiveness of Neutralization Conferred by Natural Infection or COVID-19 Vaccines in a Latino Population
    Carlos A. Sariol, Crisanta Serrano-Collazo, Edwin J. Ortiz, Petraleigh Pantoja, Lorna A. Cruz, Teresa Arana, Dianne Atehortua, Christina Pabon-Carrero, Ana Margarita Espino · 2021 · Viruses
52. Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray
    Sina Hosseinian, Kathleen Powers, Milind Vasudev, Anton M. Palma, Rafael de Assis, Aarti Jain, Peter Horvath, Paramveer Singh Birring, Rana Andary, Connie Au et al. · 2022 · Frontiers in Immunology
53. BNT162b2 COVID-19 Vaccines in Children, Adolescents and Young Adults with Cancer—A 1-Year Follow-Up
    Caroline Donzé, Victoria Min, Läétitia Ninove, Xavier Nicolas de Lamballerie, Gabriel Revon‐Rivière, Arnauld C. Verschuur, Paul Saultier, Nicolás André · 2023 · Vaccines
54. Epidemiology: Gray immunity model gives qualitatively different predictions
    Milind Watve, Himanshu Bhisikar, Rohini Kharate, Srashti Bajpai · 2024 · Journal of Biosciences
55. Modeling SARS-CoV-2 propagation using rat coronavirus-associated shedding and transmission
    Caroline J. Zeiss, Jennifer L. Asher, Brent Vander Wyk, Heather Gwynn Allore, Susan R Compton · 2021 · PLoS ONE
56. The SARS-CoV-2 Variants and their Impacts
    Amir Muhaimin Akmal Shukri, Seok Mui Wang, Suet Lin Chia, Siti Farah Alwani Mohd Nawi · 2022 · Journal of Pure and Applied Microbiology
57. Inferring COVID-19 testing and vaccination behavior from New Jersey testing data
    Ari S. Freedman, Justin K. Sheen, Stella Tsai, Jihong Yao, Edward I. Lifshitz, David Adinaro, Simon A. Levin, Bryan Thomas Grenfell, Charlotte Jessica E. Metcalf · 2024 · Proceedings of the National Academy of Sciences
58. Trust Us—We Are the (COVID-19 Misinformation) Experts: A Critical Scoping Review of Expert Meanings of “Misinformation” in the Covid Era
    Claudia Chaufan, Natalie Hemsing, Camila Heredia, Jennifer L. McDonald · 2024 · COVID
59. The Impact of Immunization with Anti-Coronavirus Vaccines on the Incidence of COVID-19 in Employees of a Large Tuberculosis Institution in Moscow
    Elena M. Bogorodskaya, I. V. Nozdrevatykh, E. L. Khristoforova, Evgeny Belilovskiy · 2022 · Epidemiology and Vaccinal Prevention
60. Combining predictive models with future change scenarios can produce credible forecasts of COVID-19 futures
    Ken Newcomb, Shakir Bilal, Edwin Michael · 2022 · PLoS ONE
61. The Blind Spot in COVID-19 Vaccination Policies: Under-Reported Adverse Events
    Patrick Provost · 2023 · International Journal of Vaccine Theory Practice and Research
62. Vaccination Provides Superior in vivo Recall Capacity of SARS-CoV-2 Specific Memory CD8 T Cells
    Inga Kavazović, Christoforos Dimitropoulos, Dora Gašparini, Mari Rončević Filipović, Igor Barković, Jan Köster, Niels A. W. Lemmermann, Marina Babić, Đurđica Cekinović, Felix M. Wensveen · 2022 · Cell Reports
63. Multiplexed on-yeast serological assay for immune escape screening of SARS-CoV-2 variants
    Joanan López-Morales, Rosario Vanella, Tamara Utzinger, Valentin Schittny, Julia R. Hirsiger, Michael Friedrich Osthoff, Christoph T. Berger, Yakir Guri, Michael A. Nash · 2023 · iScience
64. Effects of COVID-19 Mandates on College Students’ Exercise Experiences and Psychosocial Health
    Maria Kosma, Moo Song Kim, Dal-Hyun Moon, Shelia Fritts · 2023 · International Journal of Sport Exercise and Health Research
65. Total freedom in physical activity via body schema: being for itself and being in the world
    Maria Kosma · 2023 · Turkish Journal of Kinesiology
66. A risk science perspective on vaccines
    Ingrid Glette‐Iversen, Terje Aven, Roger Flage · 2023 · Risk Analysis
67. Time course of antibody concentrations against the spike protein of SARS‐CoV‐2 among healthy hospital workers up to 200 days after their first COVID‐19 vaccination
    Thomas Mueller · 2021 · Journal of Clinical Laboratory Analysis
68. Immune Response 5–7 Months after Vaccination against SARS-CoV-2 in Elderly Nursing Home Residents in the Czech Republic: Comparison of Three Vaccines
    Jan Martínek, Hana Tomášková, Jaroslav Janošek, Hana Zelená, Alena Kloudová, Jakub Mrázek, Eduard Ježo, Vlastimil Král, Jitka Pohořská, Hana Šturcová et al. · 2022 · Viruses
69. Pan-neutralizing, germline-encoded antibodies against SARS-CoV-2: Addressing the long-term problem of escape variants
    Justin Mark Lunderberg, Sanjucta Dutta, Ai-ris Yonekura Collier, Jeng-Shin Lee, Yen‐Ming Hsu, Qiao Wang, Weina Zheng, Shushun Hao, Haohai Zhang, Lili Feng et al. · 2022 · Frontiers in Immunology
70. Covid Vaccination Disputes in Czechia: Political Myth-Making and Boundary Work
    Radek Chlup · 2023 · Minerva
71. Prevalence, outcomes and associated factors of SARS-CoV-2 infection in psoriasis patients of Southwest China: a cross-sectional survey
    Yang Zou, Jing Xu, Ai-Jun Chen, Kun Huang, Shou-Min Zhu, Jian-Jun Li, Jin He, Jun-Zhi Li, Jianxia Xiong, Yu-Kun Fan et al. · 2024 · Scientific Reports
72. Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection
    Xuan He, Jiajing Jiang, Guo Li, Jinyuan Liu, Jiadi Gan, Linlin Zhou, Chunyang Bai, Qiong Zi, Xiaoli Mou, Shan Zeng et al. · 2024 · Signal Transduction and Targeted Therapy
73. COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
    M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, Russell D. Wolfinger, Nicolas Hulscher, Peter Andrew McCullough · 2024 · International Journal of Vaccine Theory Practice and Research
74. SARS-CoV-2 seroprevalence and antibody trends in vaccinated, multi-ethnic healthcare employees
    Beh C.C. · 2021 · Tropical biomedicine
75. The Characteristics of the Delta Variant of SARS-CoV-2 Virus – the Dominant Agent of the Third and Forth Waves of Epidemic COVID-19 in Russia
    T. E. Sizikova, V. N. Lebedev, D. A. Kutaev, S. V. Borisevich · 2021 · Journal of NBC Protection Corps
76. Public Choice Theory: An Explanation of the Pandemic Policy Responses
    Panagiotis Karadimas · 2023 · Studies in Public Choice
77. Neutralization Of SARS-CoV-2 Variants By A Human Polyclonal Antibody Therapeutic (COVID-HIG, NP-028) With High Neutralizing Titers To SARS-CoV-2
    Derek Toth · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
78. The Effect of Vaccination on the Competitive Advantage of Two Strains of an Infectious Disease
    Matthew D. Johnston, Bruce Pell, Jared Pemberton, David A. Rubel · 2025 · Bulletin of Mathematical Biology
79. SARS-CoV-2, the emperor’s new clothes and medical tyranny
    Deane Waldman · 2022 · Clinical Journal of Nursing Care and Practice
80. Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection
    Кулемзин Сергей Викторович, Sergey V. Guselnikov, Boris G. Nekrasov, Svetlana V. Molodykh, I. N. Kuvshinova, Svetlana V. Murasheva, Беловежец Татьяна Николаевна, Andrey A. Gorchakov, Anton N. Chikaev, Nikolai A. Chikaev et al. · 2024 · Vaccines
81. Comparative single‐cell RNA sequencing analysis of immune response to inactivated vaccine and natural SARS‐CoV‐2 infection
    Shuai He, Shu‐Qiang Liu, Xiangyun Teng, Jinyong He, Liu Yang, Jiahui Gao, Yue Wu, Wei Hu, Zhongjun Dong, Jin‐Xin Bei et al. · 2024 · Journal of Medical Virology
82. Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2
    Joanne Reekie, Henrik Stovring, Henrik Nielsen, Işık Somuncu Johansen, Thomas Benfield, Lothar Wiese, Nina Breinholt Stærke, Kasper Karmark Iversen, Ahmed Basim Mustafa, Kristine Toft Petersen et al. · 2024 · International Journal of Infectious Diseases
83. Effectiveness and Protection Duration of Anti-COVID-19 Vaccinations among Healthcare Personnel in Cluj-Napoca, Romania
    Irina Brumboiu, Edina Iuga, Andreea Ivanciuc, Sergiu Mutaffof, Alice S. Tudosa, Cristina Gherasimovici, Irina Iaru · 2023 · Vaccines
84. The Omicron Variant of SARS-CoV-2 Virus: the Ability to Cause Disease in Persons with Immunity against COVID-19
    Tatiana E. Sizikova, O. V. Chukhralya, Vitaliy N. Lebedev, Sergey V. Borisevich · 2023 · Journal of NBC Protection Corps
85. Vaccinations or Non-Pharmaceutical Interventions: Safe Reopening of Schools in England
    Carolina Cuesta-Lazaro, Arnau Quera-Bofarull, Joseph Aylett-Bullock, Bryan Lawrence, Kevin J. Fong, Miguel Icaza-Lizaola, Aidan Sedgewick, Henry Truong, Ian Vernon, Julian M. Williams et al. · 2021 · medRxiv
86. COVID-19 Acceleration and Vaccine Status in France - Summer 2021
    Christelle Baunez, Mickaël Degoulet, Stéphane Luchini, Patrick A Pintus, Miriam Teschl · 2021 · SSRN Electronic Journal
87. Reinfection with SARS-CoV-2: outcome, risk factors and vaccine efficacy in a Scottish cohort
    Paul McKeigue, David McAllister, Chris Robertson, Diane Stockton, Helen Martina Colhoun · 2021 · medRxiv
88. Protection against symptomatic disease with the delta and omicron BA.1/BA.2 variants of SARS-CoV-2 after infection and vaccination in adolescents: national observational test-negative case control study, August 2021 to March 2022, England
    Annabel A. Powell, Freja Cordelia Møller Kirsebom, Julia Stowe, Mary Elizabeth Ramsay, Jamie Lopez Bernal, Nick J Andrews, Shamez N Ladhani · 2022 · medRxiv
89. B-Cell Responses to Sars-Cov-2 mRNA Vaccines
    Lela Kardava, Clarisa M. Buckner, Susan L. Moir · 2022 · Pathogens and Immunity
90. Investigation of interaction between immobilized SARS-CoV-2 nucleoprotein and monoclonal antibodies by cyclic voltammetry based electrochemical immunosensor
    Yana Karnitskaya, Maryia Drobysh, Almira Ramanavičienė, Viktoriia V. Korniienko, Saulius Balevičius, Arūnas Ramanavičius · 2025 · Microchemical Journal
91. High Level of SARS-CoV-2 Infection in Young Population Is a Predictor for Peak Incidence
    Haeyoun Choi, Sun Young Shin, Seung‐Jin Hong, Sang‐Uk Seo, Mun‐Gan Rhyu · 2022 · Frontiers in Microbiology
92. The course of patients with hairy cell leukemia during the omicron surge of the Covid‐19 pandemic
    Tamar Tadmor, Guy Melamed, Tal Patalon, Hilel Alapi, Lior Rokach · 2023 · Hematological Oncology
93. COVID-19 vaccine in hemodialysis patients
    Waleed H. Mahallawi · 2023 · Saudi Medical Journal
94. Duration of protective immunity following COVID‐19 vaccination of individuals with underlying health conditions: A rapid review
    Kieran Anthony Walsh, Helen O’Donnell, Mark O’Loughlin, Heather Eames, Jingjing Jiang, Katie M. O’Brien, Natasha Broderick, Kirsty K O’Brien, Marie Carrigan, Laura Comber et al. · 2024 · Reviews in Medical Virology
95. Elucidating the Immune Response to SARS-CoV-2: Natural Infection versus Covaxin/Covishield Vaccination in a South Indian Population
    Agalya Vanamudhu, Renuka Devi Arumugam, Arul Nancy, Nandhini Selvaraj, Kadar Moideen, Syed S Hissar, Uma Devi Ranganathan, Ramalingam Bethunaickan, Subash Babu, Nathella Pavan Kumar · 2024 · Viruses
96. Does SARS-CoV-2 Possess “Allergen-Like” Epitopes?
    Alberto Rubio‐Casillas, David Cowley, Vladimir Nikolaevich Uversky, Elrashdy M Moustafa Mohamed Redwan, Carlo Brogna, Marina Piscopo · 2025 · COVID
97. Development of multivalent SARS-CoV-2 virus-like particle vaccine candidates
    Urban Bezeljak, Alexander Jerman, Tina Kobal, Elfi Birsa, Martina Lokar Kosmač, Rok Žiberna, Krista Lokar, Nika Janež, Sanda Ravlić, Beata Halassy et al. · 2025 · Vaccine
98. COVID-19 and the Unraveling of Experimental Medicine - Part II
    K. E. Thorp, James A. Thorp · 2022 · The Gazette of Medical Sciences
99. COVID-19 Vaccine Acceptance and Hesitancy among Health Care Workers (HCWs) In Two Major Urban Centers in Khyber-Pakhtunkhwa, Pakistan
    Sajjad Khan, Azhar Uddin, Muhammad Imran, Yousaf Ali, Shahid Ullah Khan, Muhammad Salman Khan, Beverley Trutter, Momina Asfandiyar, Zafar Iqbal · 2022 · Asia Pacific Journal of Public Health
100. Real-World Incidence of Breakthrough Coronavirus Disease 2019 Hospitalization After Vaccination vs Natural Infection in a Large, Local, Empaneled Primary Care Population Using Time-to-Event Analysis
     Benjamin D. Pollock, Curtis B. Storlie, Aaron Joseph Tande, Priya Sampathkumar · 2022 · Clinical Infectious Diseases